GENE ONLINE|News &
Opinion
Blog

R&D
R&D
ASCO 2020: Results from the INFORM Registry, A Step Towards Personalized Therapy in Pediatric Cancer
2020-05-29
R&D
ASCO 2020: Maintenance Therapy with Avelumab Post-Chemo Improves Overall Survival of Bladder Cancer Patients
2020-05-29
Breakthrough Stem Cell Therapy Research Shows Repair in Multiple Sclerosis Damage
2020-05-24
Long-Acting Cabotegravir Injection Performs Better as an HIV PrEP than Daily Pills
2020-05-22
Vividion Inks $135 Million Deal with Roche for Targeted Protein Degraders
2020-05-20
R&D
Spotlight: The Many Facets of AstraZeneca’s Farxiga
2020-05-15
R&D
Diabetes: Novel Amylin, Insulin Coformulation Could Aid Blood-Sugar Control
2020-05-14
AACR 2020 – Changing the Immunotherapy Paradigm
2020-05-08
R&D
AACR 2020: Modifications in Tumor Microenvironment and Host Microbiome, a Potential Therapeutic Strategy for Immunotherapy
2020-05-08
AACR 2020: Targeting the KRAS Pathway – Old Protein, New Approaches
2020-04-30
R&D
AACR 2020 Conference – Recent Advances in Breast Cancer Treatments
2020-04-29
R&D
AACR 2020 Conference – Advances in the Field of Lung Cancer Targeted Therapies
2020-04-28
CAR-T Therapy – a Boon for Cancer Treatment?
2020-04-27
Gilead, Kite, and oNKo-innate Collaborate to Advance Cancer Immunotherapy Using NK Cells
2020-04-26
CRISPR Helps Unearth Novel drug Target for Leukemia
2020-04-23
1 27 28 29 30 31 34
LATEST
UC Riverside Scientists Unveil RNA-based Vaccine Strategy, Potentially Avoiding Endless Booster Shots
2024-05-02
Lilly’s Q1 2024 Financial Report: Full-Year Revenue Outlook Raised by $2 Billion, with a 67% Net Income Increase
2024-05-02
Taiwan Breakthrough: Next-Generation Sequencing Now Covered in Health Insurance, Benefitting 20,000 Cancer Patients Annually
2024-05-02
CellTech Accelerator and Cyto-Facto Inc. Forge Strategic Partnership to Advance CGT Industry Growth
2024-04-29
Kaiser’s Data Breach: 13.4 Million Affected in Healthcare Conglomerates Privacy Crisis
2024-04-26
Mechanisms of Allograft Rejection: Insights from Behind the Scenes
2024-04-25
ImmunityBio’s ANKTIVA® Granted FDA Approval: Breakthrough IL-15 Receptor Agonist First-in-Class for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
2024-04-24
EVENT
Scroll to Top